TG Therapeutics, a biopharmaceutical company, develops agents for the treatment of hematologic malignancies and autoimmune disorders. read more
TG Therapeutics CEO & Leadership Team Ratings
Michael Weiss and the TG Therapeutics leadership team are scored a D by 14 employees placing it in the Bottom 20% of companies sized 11-50 Employees on Comparably. The Leadership score includes details about how employees evaluate their executive team, CEO and manager.
Caucasian employees have the most favorable ratings for their leadership team.
Based on 53 ratings, the Leadership score of 57/100 combines employee feedback on their CEO (69/100), Manager (59/100), and Executive Team (58/100).
Michael Weiss TG Therapeutics CEO Rating
Bottom 40% Compared to other companies of similar size in New YorkC
69 / 100
Michael Weiss the CEO of TG Therapeutics received an average score of 69 from TG Therapeutics employees.Female employees at TG Therapeutics rate the CEO the highest.
Caucasian employees at TG Therapeutics rate the CEO the highest.
TG Therapeutics Manager Rating
Bottom 15% Compared to other companies of similar size in New YorkD
59 / 100
TG Therapeutics Executive Team Rating
Bottom 20% Compared to other companies of similar size in New YorkD
58 / 100
×